Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuromuscular Blockade Depth in ARDS
NCT06514209Recruiting
- Sponsor
- Southeast University
- Start
- Jun 2024
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of cisatracurium in acute respiratory distress syndrome (ARDS), sponsored by Southeast University. Primary endpoint: Transpulmonary Pressure. Started Jun 2024; status: recruiting.
02
Drugs
cisatracurium
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT06514209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06514209.